Your search resulted in multiple matches. Please select a position:

Gencode Genes

CDCP1 (ENST00000296129.6) at chr3:45082277-45146378 - Homo sapiens CUB domain containing protein 1 (CDCP1), transcript variant 1, mRNA. (from RefSeq NM_022842)
CDCP1 (ENST00000490471.1) at chr3:45112337-45139595 - CUB domain containing protein 1 (from HGNC CDCP1)
CDCP1 (ENST00000425231.2) at chr3:45110216-45146422 - Homo sapiens CUB domain containing protein 1 (CDCP1), transcript variant 2, mRNA. (from RefSeq NM_178181)
CDH2 (ENST00000399380.7) at chr18:27951081-28036585 - Homo sapiens cadherin 2 (CDH2), transcript variant 2, mRNA. (from RefSeq NM_001308176)
CDH2 (ENST00000269141.8) at chr18:27950966-28177130 - Homo sapiens cadherin 2 (CDH2), transcript variant 1, mRNA. (from RefSeq NM_001792)
SDC1 (ENST00000381150.5) at chr2:20200799-20225433 - Homo sapiens syndecan 1 (SDC1), transcript variant 1, mRNA. (from RefSeq NM_001006946)
SDC1 (ENST00000254351.9) at chr2:20200797-20225130 - Homo sapiens syndecan 1 (SDC1), transcript variant 2, mRNA. (from RefSeq NM_002997)
SDC4 (ENST00000372733.3) at chr20:45325288-45348424 - Homo sapiens syndecan 4 (SDC4), mRNA. (from RefSeq NM_002999)
CDH3 (ENST00000429102.6) at chr16:68644993-68699036 - Homo sapiens cadherin 3 (CDH3), transcript variant 2, mRNA. (from RefSeq NM_001317195)
CDH3 (ENST00000264012.9) at chr16:68645310-68700292 - Homo sapiens cadherin 3 (CDH3), transcript variant 1, mRNA. (from RefSeq NM_001793)
ST14 (ENST00000278742.6) at chr11:130159782-130210362 - Homo sapiens suppression of tumorigenicity 14 (ST14), mRNA. (from RefSeq NM_021978)
PRKCG (ENST00000263431.4) at chr19:53882197-53907652 - Homo sapiens protein kinase C gamma (PRKCG), transcript variant 2, mRNA. (from RefSeq NM_002739)
PRKCD (ENST00000652449.1) at chr3:53161217-53192487 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 7, mRNA. (from RefSeq NM_001354680)
PRKCD (ENST00000650739.1) at chr3:53161356-53192558 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 6, mRNA. (from RefSeq NM_001354679)
PRKCD (ENST00000394729.6) at chr3:53161120-53192717 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 2, mRNA. (from RefSeq NM_212539)
PRKCD (ENST00000330452.8) at chr3:53161209-53192717 - Homo sapiens protein kinase C delta (PRKCD), transcript variant 1, mRNA. (from RefSeq NM_006254)
SRC (ENST00000373578.6) at chr20:37346154-37406050 - Homo sapiens SRC proto-oncogene, non-receptor tyrosine kinase (SRC), transcript variant 2, mRNA. (from RefSeq NM_198291)
SRC (ENST00000373567.6) at chr20:37383668-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000373558.2) at chr20:37384150-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000358208.8) at chr20:37382604-37405432 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_022842.4 at chr3:45082274-45146422
NM_178181.2 at chr3:45110216-45146422

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_011534024.1 at chr3:45082277-45146383
XM_017007070.1 at chr3:45082277-45146408
XM_024453718.1 at chr3:45082277-45146410

NCBI RefSeq and Ensembl transcripts from the MANE Project (v0.6)

CDCP1 at chr3:45082277-45146378

RefSeq Genes

CDCP1 at chr3:45110216-45146422 - (NM_178181) CUB domain-containing protein 1 isoform 2 precursor
CDCP1 at chr3:45082277-45146378 - (NM_022842) CUB domain-containing protein 1 isoform 1 precursor

Non-Human RefSeq Genes

Cdcp1 at chr3:45084772-45146295 - (NM_001106869) CUB domain-containing protein 1 precursor
Cdcp1 at chr3:45084806-45146308 - (NM_133974) CUB domain-containing protein 1 precursor

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

CDCP1 at chr3:45082277-45146378
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

CDCP1 at chr3:45082277-45146378
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

CDCP1 at chr3:45082278-45146422
CDCP1 at chr3:45110216-45146422
CDCP1 at chr3:45112337-45139595

International Knockout Mouse Consortium Genes Mapped to Human Genome

Cdcp1_41798 at chr3:45082277-45146422
Cdcp1_VG12591 at chr3:45082277-45146422

Human Aligned mRNA Search Results

BC069254 - Homo sapiens CUB domain containing protein 1, mRNA (cDNA clone IMAGE:4589711), partial cds.
AY026461 - Homo sapiens CUB domain containing protein 1 (CDCP1) mRNA, complete cds.
AY375452 - Homo sapiens membrane glycoprotein gp140 (CDCP1) mRNA, partial cds.
BC021099 - Homo sapiens CUB domain containing protein 1, mRNA (cDNA clone IMAGE:4590554), complete cds.
KU257676 - Homo sapiens CUB domain-containing protein 1 (CDCP1) mRNA, partial cds.

Non-Human Aligned mRNA Search Results

BC011340 - Mus musculus CUB domain containing protein 1, mRNA (cDNA clone IMAGE:3709937), partial cds.
BC018410 - Mus musculus CUB domain containing protein 1, mRNA (cDNA clone IMAGE:4014852), partial cds.
BC050137 - Mus musculus CUB domain containing protein 1, mRNA (cDNA clone IMAGE:6430624), partial cds.
BC085253 - Mus musculus CUB domain containing protein 1, mRNA (cDNA clone MGC:102289 IMAGE:5347122), complete cds.
KU257677 - Mus musculus CUB domain-containing protein 1 (Cdcp1) mRNA, partial cds.